Innovation

Rapid, High-Purity, Low-Cost Purification System for Recombinant Proteins

University Health Network - Technology Development and Commercialization
posted on 05/26/2010

Rapid, High-Purity, Low-Cost Purification System for Recombinant Proteins


Innovation Details
 

Detailed Description

Therapeutic proteins, subunit vaccines, as well as recombinant proteins for research use must all be recovered in a pure and functional state. To address this problem - UHN researchers have developed a novel tandem - (His) 6-calmodulin (HiCaM) - fusion tag that combines two distinct purification strategies, namely immobilized metal-affinity (IMAC) and hydrophobic interaction chromatography (HIC), in a simple and rapid two-step procedure.

Advantages of Technology:
  • Requires little-to-no optimization in order to achieve ~99% purity.
  • Utilizes a single buffer system which avoids time-consuming exchanges between purification steps.
  • Uses a small affinity tag (6xHis-CaM, ~19 Kd) that is completely removed upon cleavage with thrombin.
  • Requires inexpensive binding matrices compared to those used in competing purification strategies (currently quoted prices by GE Healthcare: $2.80 USD/mL Phenyl sepharose 6 FF required for HiCaM system vs. $34 USD/mL IgG sepharose 6 FF required for TAP-tag system).
  • Is easily adapted for any other expression vector (bacterial, yeast or mammalian).
  • Overcomes common limitations such as non-specific binding, loss of function due to changes in native protein confirmation and co-elution of host proteins.

Related Publication:
McCluskey, A.J., Poon, G.M. and Gariépy, J. A rapid and universal tandem-purification strategy for recombinant proteins. Protein Sci. 16(12):2726-32 (2007)

File Number: 7011 

Other Information: Inventors: Jean Gariepy, Andrew McCluskey and Gregory Poon


IP Protection

Patent Number(s): US12/682,718

License Online

This innovation currently is not available for online licensing. Please contact Thomas Parsons at University Health Network - Technology Development and Commercialization for more information.

Request more info via email request more info
People

Case Manager:

Thomas Parsons Thomas Parsons

Innovations (13)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Communities
Profile
Related Tags

Find more innovations


February 11, 2009

7,868 members 17,196 innovations 152 organizations

Browse

Dr. Jörg Knäblein – Technology Scouting, Bayer Schering Pharma AG

"Through the iBridge Network, I was able to find a mouse model I was looking for. The collaboration available through the iBridge Network is crucial in driving innovation and I'll continue using it as a valued resource."  read more...